Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
HCT116(RCB2979)
|
69988
|
In Vitro and In Silico Study of Analogs of Plant Product Plastoquinone to Be Effective in Colorectal Cancer Treatment.
|
Molecules |
2022-1-21 |
Pubmed
Full text
|
Human and Animal Cells
|
JLS-V9(RCB2651)
|
68909
|
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model.
|
Cancer Lett |
2021-2-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HF19(RCB0210)
|
65143
|
Synthesis, docking, cytotoxicity, and LTA4H inhibitory activity of new gingerol derivatives as potential colorectal cancer therapy.
|
Bioorg Med Chem |
2017-2-1 |
Pubmed
Full text
|
Human and Animal Cells
|
Ehrlich(RCB0142)
|
63117
|
Chemical and molecular bases of dome formation in human colorectal cancer cells mediated by sulphur compounds from Cucumis melo var. conomon.
|
FEBS Open Bio |
2020-12-1 |
Pubmed
Full text
|
Human and Animal Cells
|
CACO-2(RCB0988)
|
63032
|
Low‑dose trametinib and Bcl‑xL antagonist have a specific antitumor effect in KRAS‑mutated colorectal cancer cells.
|
Int J Oncol |
2020-11-1 |
Pubmed
Full text
|
Human and Animal Cells
|
COLO205(RCB2127)
,
JHCOLOYI(RCB1706)
,
PMF-ko14(RCB1426)
|
62298
|
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer.
|
Mol Cancer Res |
2017-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
CACO-2(RCB0988)
|
61343
|
Augmented pentose phosphate pathway plays critical roles in colorectal carcinomas.
|
Oncology |
2015-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
CHO-K1
|
59868
|
Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer-specific molecule.
|
Cancer Sci |
2019-2-1 |
Pubmed
Full text
|
Human and Animal Cells
|
Sa3(RCB0980)
,
LU65(RCB1967)
|
58779
|
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer.
|
Cancer Immunol Immunother |
2020-6-1 |
Pubmed
Full text
|
Human and Animal Cells
|
293T(RCB2202)
|
58738
|
Upregulation of nuclear factor (erythroid-derived 2)-like 2 protein level in the human colorectal adenocarcinoma cell line DLD-1 by a heterocyclic organobismuth(III) compound: Effect of organobismuth(III) compound on NRF2 signaling.
|
Biomed Pharmacother |
2020-5-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HCT116(RCB2979)
|
57752
|
Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.
|
Cancer Chemother Pharmacol |
2019-6-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PANC-1(RCB2095)
|
52247
|
The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
|
PLoS One |
2017-5-30 |
Pubmed
Full text
|
Human and Animal Cells
|
CACO-2(RCB0988)
|
51594
|
Phosphorylated retinoblastoma protein is a potential predictive marker of irinotecan efficacy for colorectal cancer.
|
Int J Oncol |
2016-3-1 |
Pubmed
Full text
|
Human and Animal Cells
|
CW-2(RCB0778)
|
45129
|
Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.
|
PLoS One |
2014-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
LoVo(RCB1639)
,
COLO-320(RCB1193)
|
44807
|
Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer.
|
Int J Cancer |
2014-12-1 |
Pubmed
Full text
|
Human and Animal Cells
|
MKN74(RCB1002)
|
38127
|
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
|
Anticancer Res |
2015-9-1 |
Pubmed
|
DNA material
|
CSII-EF-MCS (RDB04378)
|
34735
|
RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells.
|
J Biol Chem |
2015-3-6 |
Pubmed
Full text
|
Human and Animal Cells
|
MKN74(RCB1002)
|
19374
|
In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer.
|
Anticancer Res |
2009-8-1 |
Pubmed
|